605 related articles for article (PubMed ID: 24140083)
1. Targeting tumor-stromal interactions in bone metastasis.
Esposito M; Kang Y
Pharmacol Ther; 2014 Feb; 141(2):222-33. PubMed ID: 24140083
[TBL] [Abstract][Full Text] [Related]
2. Bone metastasis and the metastatic niche.
Ren G; Esposito M; Kang Y
J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
[TBL] [Abstract][Full Text] [Related]
3. Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.
Schneider JG; Amend SR; Weilbaecher KN
Bone; 2011 Jan; 48(1):54-65. PubMed ID: 20850578
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis.
Graham N; Qian BZ
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642534
[TBL] [Abstract][Full Text] [Related]
5. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
[TBL] [Abstract][Full Text] [Related]
6. The Endosteal Niche in Breast Cancer Bone Metastasis.
Haider MT; Smit DJ; Taipaleenmäki H
Front Oncol; 2020; 10():335. PubMed ID: 32232008
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications.
Zheng H; Li W; Kang Y
Cold Spring Harb Symp Quant Biol; 2016; 81():151-161. PubMed ID: 28381439
[TBL] [Abstract][Full Text] [Related]
8. Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche.
Shahriari K; Shen F; Worrede-Mahdi A; Liu Q; Gong Y; Garcia FU; Fatatis A
Oncogene; 2017 May; 36(20):2846-2856. PubMed ID: 27991924
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.
Kaplan RN; Psaila B; Lyden D
Cancer Metastasis Rev; 2006 Dec; 25(4):521-9. PubMed ID: 17186383
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic targets for cancer bone metastasis.
Krzeszinski JY; Wan Y
Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
[TBL] [Abstract][Full Text] [Related]
11. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
[TBL] [Abstract][Full Text] [Related]
12. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.
Shiozawa Y; Pienta KJ; Taichman RS
Clin Cancer Res; 2011 Sep; 17(17):5553-8. PubMed ID: 21676926
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow/bone pre-metastatic niche for breast cancer cells colonization: The role of mesenchymal stromal cells.
Sanmartin MC; Borzone FR; Giorello MB; Pacienza N; Yannarelli G; Chasseing NA
Crit Rev Oncol Hematol; 2021 Aug; 164():103416. PubMed ID: 34237436
[TBL] [Abstract][Full Text] [Related]
15. The metastatic niche formation: focus on extracellular vesicle-mediated dialogue between lung cancer cells and the microenvironment.
Pontis F; Roz L; Fortunato O; Bertolini G
Front Oncol; 2023; 13():1116783. PubMed ID: 37207158
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells development into osteoclast-type APCs by 4T1 breast tumor T cells milieu boost bone consumption.
Monteiro AC; Bonomo A
Bone; 2021 Feb; 143():115755. PubMed ID: 33217627
[TBL] [Abstract][Full Text] [Related]
17. Disruption of crosstalk between mesenchymal stromal and tumor cells in bone marrow as a therapeutic target to prevent metastatic bone disease.
Gordon JA; Lisle JW; Alman BA; Lian JB
J Cell Physiol; 2014 Dec; 229(12):1884-6. PubMed ID: 24905746
[TBL] [Abstract][Full Text] [Related]
18. Immune Modulation of Metastatic Niche Formation in the Bone.
Cheng X; Wang Z
Front Immunol; 2021; 12():765994. PubMed ID: 34745140
[TBL] [Abstract][Full Text] [Related]
19. Tumor-stromal interactions in bone metastasis.
Nannuru KC; Singh RK
Curr Osteoporos Rep; 2010 Jun; 8(2):105-13. PubMed ID: 20425618
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
